Literature DB >> 22175886

Clinicopathological correlates and prognostic significance of glutathione S-transferase Pi expression in 468 patients after potentially curative resection of node-positive colonic cancer.

King L Tan1, Lucy Jankova, Charles Chan, Caroline L-S Fung, Candice Clarke, Betty P C Lin, Graham Robertson, Mark Molloy, Pierre H Chapuis, Les Bokey, Owen F Dent, Stephen J Clarke.   

Abstract

AIMS: This study investigated the association between glutathione S-transferase Pi (GST Pi) expression, histopathology and overall survival in 468 patients after resection of stage C colonic adenocarcinoma. METHODS AND
RESULTS: Data were drawn from a prospective hospital registry of consecutive bowel cancer resections with a minimum follow-up of 5 years. Nuclear and cytoplasmic GST Pi expression, assessed by both intensity of staining and percentage of stained cells at both the central part of the tumour and the invasive tumour front, were evaluated retrospectively by tissue microarray immunohistochemistry on archival specimens. The most effective measure of GST Pi expression was the percentage of immunostained nuclei in central tumour tissue, where >40% stained was associated significantly with high grade, invasion beyond the muscularis propria, involvement of a free serosal surface or apical node, and invasion into an adjacent organ or structure. After adjustment of other predictors, GST Pi expression remained independently prognostic for reduced overall survival (hazard ratio 1.4, P = 0.002).
CONCLUSIONS: In patients with clinicopathological stage C colonic cancer, GST Pi expression is associated with features of tumour aggressiveness and with reduced overall survival. Further appropriately designed studies should aim to discover whether GST Pi can predict response to adjuvant chemotherapy.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22175886     DOI: 10.1111/j.1365-2559.2011.04044.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  HNF4α: a new biomarker in colon cancer?

Authors:  Karthikeyani Chellappa; Graham R Robertson; Frances M Sladek
Journal:  Biomark Med       Date:  2012-06       Impact factor: 2.851

2.  Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study.

Authors:  Lucy Jankova; Graham Robertson; Charles Chan; King L Tan; Maija Kohonen-Corish; Caroline L-S Fung; Candice Clarke; Betty P C Lin; Mark Molloy; Pierre H Chapuis; Les Bokey; Owen F Dent; Stephen J Clarke
Journal:  BMC Cancer       Date:  2012-05-28       Impact factor: 4.430

Review 3.  Activating p53 function by targeting RLIP.

Authors:  Sharad S Singhal; David Horne; Jyotsana Singhal; Sanjay Awasthi; Ravi Salgia
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-01-15       Impact factor: 11.414

4.  Glutathione S-transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma.

Authors:  Shinpei Ogino; Hirotaka Konishi; Daisuke Ichikawa; Daiki Matsubara; Katsutoshi Shoda; Tomohiro Arita; Toshiyuki Kosuga; Shuhei Komatsu; Atsushi Shiozaki; Kazuma Okamoto; Mitsuo Kishimoto; Eigo Otsuji
Journal:  Cancer Sci       Date:  2018-12-21       Impact factor: 6.716

5.  Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers.

Authors:  Barak Rotblat; Thomas G P Grunewald; Gabriel Leprivier; Gerry Melino; Richard A Knight
Journal:  Oncotarget       Date:  2013-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.